Cited by 654Inflammasome and immune disordersImmunodeficiency and Autoimmune DisordersImmune Response and Inflammation

Interleukin-1–Receptor Antagonist in the Muckle–Wells Syndrome

Open access
Hawkins, Philip N., Lachmann, Helen J., McDermott, Michael F.·2003·New England Journal of Medicine

Abstract

To the Editor: Studies of hereditary inflammatory disorders have identified novel genes and pathways that may be involved in inflammation and apoptosis generally. Mutations in one such gene, variou...

Integrity signals

Registry

Crossref · 10.1056/nejm200306193482523

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Anakinra, an IL-1 receptor antagonist, is used effectively to treat autoinflammatory syndromes and gout in patients.

    “Since Anakinra (IL-1ra) is efficiently used in the clinical treatment of autoinflammatory syndromes (26) as well as gout patients (27), the present study suggests a potential use of Anakinra in order to slow down progression of asbestosis, silicosis and possibly other inflammatory lung diseases.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hawkins, P. N., Lachmann, H. J., & McDermott, M. F.
Venue
New England Journal of Medicine
Published
2003-06-19
Volume
348
Issue
25
Pages
2583-2584
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W1996264333
Cited by
654
References
5
Citations by year
2026: 3 · 2025: 1 · 2024: 5 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 13 · 2019: 15 · 2018: 12 · 2017: 18 · 2016: 15 · 2015: 23 · 2014: 15 · 2013: 31 · 2012: 29
FWCI
31.72
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
interleukin-1 receptor antagonist, Muckle-Wells syndrome, IL1R1, inflammation, apoptosis, genetic mutations
MeSH terms
Amyloidosis, Humans, Male, Nephrotic Syndrome, Recombinant Proteins, Sialoglycoproteins, Syndrome, Receptors, Interleukin-1, Interleukin 1 Receptor Antagonist Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review